Ripfit Peptides

Product Details

Tirzepatide is a dual agonist of the GLP-1 and GIP receptors, designed to investigate incretin-based signaling pathways in controlled experimental settings. In preclinical research, it is used to study mechanisms related to glucose regulation, metabolic homeostasis, insulin signaling, and appetite-related pathways through its simultaneous engagement of two key metabolic receptors. This dual-action profile makes Tirzepatide a valuable reagent for examining complex endocrine interactions, hormone-receptor dynamics, and metabolic peptide combinations in laboratory models.

For laboratory and in-vitro research only. Not for human consumption. COAs available on request.